RxDoctor Payments Data

Manish Patel, MD

Hand Surgery · Austin, TXNPI 1114031929

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (40.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Arthrex at 40.9% of the total. Reporting peaked in 2019 at $4,004 and has fallen 72.9% since, to $1,086 in 2025.

$8,532in general payments, 2019–2025

Across 69 payments — averaging $123.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3K
  • Medinc Of Texas$2K
  • Alafair Biosciences, Inc.$819
  • Core Surgical Group$561
  • Abbott$395
  • Nalu Medical, Inc.$310
  • plus $1K from 20 others

What the payments were for

  • Consulting fees$7008%
  • Travel & lodging$1,99623%
  • Food & beverage$2,38028%
  • Education$3,45641%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,532 in reported general payments places this provider in the 65th percentile of 170 hand surgery providers in Texas.

See all hand surgery providers in Texas

Medicare billing

Part B allowed, 2024
$81,666
Medicare patients
126
Services billed
517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib17$656
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$374
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$283
Ondansetron OdtOndansetron18$206
Meloxicam38$126
Tramadol Hcl41$92
Methylprednisolone14$83

Paid to pharmacies, not to this prescriber.

Other hand surgery in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →